Market Reports

What Market Size Is Projected For The Claudin 18.2 Targeted Therapy Market By 2030? The claudin 18.2 targeted therapy market size has grown exponentially in recent years. It will grow from $1.6 billion in 2025 to $1.98 billion in 2026 at a compound annual growth rate (CAGR) of 23.7%. The growth in the historic period can be attributed to increasing prevalence of gastric and gastrointestinal cancers, advancements in antibody engineering technologies, expansion of oncology-focused clinical trials, rising investments in targeted cancer therapies, improved understanding of claudin protein biology. The claudin 18.2 targeted therapy market size is expected to see exponential growth in the next few years. It will grow to $4.61 billion in 2030 at a compound annual growth rate (CAGR) of 23.5%. The growth in the forecast period can be attributed to increasing regulatory approvals for targeted oncology drugs, rising demand for personalized cancer treatment, expansion of combination therapy approa...